A Culturally Specific End-of-life Communication Skills Training
NCT ID: NCT05888480
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
148 participants
INTERVENTIONAL
2023-09-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is: What is the effectiveness of culturally specific end-of-life CST among Chinese oncology nurses? Participants will receive an 8-week communication skills training. Researchers will compare the intervention group and the wait-list group to see if skills, self-efficacy, and outcome expectancy beliefs will be improved.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
End-of-life Communication From a Chinese Perspective
NCT05734781
Nurse-led Care Program for Cancer Patients in Chemotherapy Day Center
NCT02228200
Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer
NCT00827333
An Interactive Advance Care Planning Intervention to Facilitate a Good Death for Cancer Patients
NCT01912846
Communication Skill and Related Factors Among Oncology Nurses
NCT05788809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design and participants: It is designed as a single-blind, pre-post randomized controlled trial (RCT). Registered nurses who work with advanced cancer patients in hospital settings will be recruited. The participants will be randomly assigned to either the intervention group (IG) or the control group (CG). The IG will receive the end-of-life CST between the two measurement points, and the CG will be a waitlist group and receive the training after the end of data collection.
Data analysis: Demographic information about the participants will be summarised in descriptive statistics. Independent t-tests and chi-square tests are used to investigate the comparability of groups in terms of the demographics generated by randomization. The primary and secondary outcome variables will be examined using covariate-adjusted linear mixed models. This approach enables the consideration of missing data. For non-repeated continuous measurements, ordinary linear regression and logistic models will be adopted. The intention-to-treat (ITT) analysis and post hoc analyses of contaminated data will be performed.
Expected results: Nurses' skills, self-efficacy, and outcome expectancy beliefs will improve after the CST.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group (IG)
The IG will receive the end-of-life CST between the two measurement points
The end-of-life communication skills training
Training methods include lectures, video demonstrations, and simulation in small groups (4-5 trainees per group with multidisciplinary roles). Written and audiovisual learning materials will be offered. Each session will be 150 minutes, including lectures and video demonstration (90 min/session) and simulation and feedback (60 min/session). One session will be conducted in two weeks. Totally there will be four sessions completed in 8 weeks.
Control group (CG)
The CG will be a waitlist group and receive the training after the end of data collection.
Routine training activity
Routine training activities arranged by relevant departments in hospitals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The end-of-life communication skills training
Training methods include lectures, video demonstrations, and simulation in small groups (4-5 trainees per group with multidisciplinary roles). Written and audiovisual learning materials will be offered. Each session will be 150 minutes, including lectures and video demonstration (90 min/session) and simulation and feedback (60 min/session). One session will be conducted in two weeks. Totally there will be four sessions completed in 8 weeks.
Routine training activity
Routine training activities arranged by relevant departments in hospitals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consent to participate in the study
Exclusion Criteria
* Specialized nurses in palliative care
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hong Kong Polytechnic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Joyce Chung
Assistant Professor, School of Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joyce Chung, PhD
Role: PRINCIPAL_INVESTIGATOR
The Hong Kong Polytechnic University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSEARS20230525002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.